ADCY1 inhibitor/activator/substrate/reporter | 5 products cited in the literature; 6 total from 4 suppliers

Your Filters

product

1099/10
Tocris Bioscience
catalog: 1099/10

citations: 99

Cat.No. 1099 - Forskolin C22H34O7 CAS No. 66575-29-9
quantity: 10 mg (also 50 mg)
price: 212 USD
to the supplier
1435/10
Tocris Bioscience
catalog: 1435/10

citations: 12

Cat.No. 1435 - SQ 22536 C9H11N5O CAS No. 17318-31-9
quantity: 10 mg (also 50 mg)
price: 212 USD
to the supplier
1603/10
Tocris Bioscience
catalog: 1603/10

citations: 7

Cat.No. 1603 - NKH 477 C27H43NO8.HCl CAS No. 138605-00-2
quantity: 10 mg (also 50 mg)
price: 289 USD
to the supplier
Forskolin
Alomone Labs
catalog: F-500

citations: 8

Alomone Labs Forskolin activates (in vivo)adenylate cyclase in NIH/C6 neuroblastoma cells. - Cells were pre-incubated for 30 min with IBMX (10 mM) and then stimulated for 30 min with different concentrations ofForskolin(#F-500). Cellular cAMP levels were measured by an ELISA kit.
quantity:
price:
to the supplier
Forskolin
StressMarq Biosciences
catalog: SIH-208

citations: 2

Chemical structure of Forskolin (SIH-208), a Adenylate cyclase activator. CAS #: 66575-29-9. Molecular Formula: C22H34O7. Molecular Weight: 410.51 g/mol.
quantity: 10 mg
price:
to the supplier
Forskolin, Adenylyl cyclase activator
Abcam
catalog: ab120058

quantity: 100 mg
price:
to the supplier

Filters

suppliers:
- Abcam [1]
  Alomone Labs [1]
  
  StressMarq Biosciences [1]
  Tocris Bioscience [3]

gene information - human ADCY1

- synonym:AC1; DFNB44
- description:adenylate cyclase 1

do you know?

we limit the listing of re-branded antibodies to provide our visitors with accurate information and the best experience
we manually curate antibody information from the literature to obtain a comprehensive set of well-validated antibodies.
we limit citation information for polyclonal antibodies to articles published within the last 5 years because the supply of a particular polyclonal antibody preparation is limited.

product type

related gene

linkout

questions and comments